Source: BIOPORTFOLIO

Spinifex: MultiMillionDollar Deal Brings UQ Pain Drug Closer to Reality

A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use with a global pharmaceutical giant acquiring the Australianfounded company developing the drug.Spinifex Pharmaceuticals has been acquired by Novartis Inter...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Tom McCarthy's photo - President & CEO of Spinifex Pharmaceuticals Pty. Ltd.

President & CEO

Tom McCarthy

CEO Approval Rating

66/100

Read more